Supreme Court Snubs Ban, Prisons Stunned

The Supreme Court left in place a lower-court order requiring federal prisons to keep providing hormone therapy and related accommodations to transgender inmates, rejecting the administration’s emergency bid to curb that care.

Story Snapshot

The Supreme Court denied an emergency appeal to restrict inmate hormone therapy, with two justices dissenting.
A prior injunction requires the Bureau of Prisons to continue hormones and social accommodations for a certified class.
The administration argues these interventions are medically disputed and security risks, citing an administrative record.
The case continues on the merits while prisons must follow the injunction and prior care standards.

What The Supreme Court’s Denial Means Right Now

The Supreme Court declined an emergency request from the administration to pause a lower-court order. That order requires the Bureau of Prisons to keep providing hormone therapy and social accommodations for transgender inmates diagnosed with gender dysphoria while the case proceeds. Two justices dissented. The decision does not end the lawsuit. It means the current care must continue during the appeal, unless a later ruling changes it.

A federal judge issued the key order in June 2025. That ruling both granted a preliminary injunction and certified a class of transgender inmates with gender dysphoria. The judge found prison officials could not cut off care that their own medical staff had approved, at least while the case is being heard. News reports describe the order as protecting access to hormones and social accommodations, not as a final judgment on surgery requests.

How We Got Here: Policy Shift And Court Pushback

The plaintiffs say the government moved from case-by-case care to a blanket ban after Executive Order 14168 in January 2025. Their complaint claims the new policy barred gender-affirming health care regardless of medical need and even for people already on treatment. Earlier, a temporary restraining order in Washington, D.C. blocked the Bureau of Prisons from stopping prescribed hormones for three women and from transferring them to men’s prisons while the suit advanced.

A Bureau of Prisons policy document later acknowledged the agency must follow the June 3, 2025 injunction. That means continuing hormone therapy and social accommodations under the prior standards while the litigation proceeds. This keeps the earlier, individualized approach in effect, at least for now, despite the executive order and the agency’s later policy shift announced by the administration.

The Administration’s Case: Security, Science, And Scope

The administration told the Supreme Court that federal prisons should focus on mental-health care for gender dysphoria and move away from hormones, surgeries, and social accommodations. Officials called these interventions medically disputed and not justified in prison settings. They also cited prison security and administration concerns as reasons to change policy. Reports say the government referenced a large administrative record and a memorandum to support that shift.

🔴 Supreme Court preserves prison gender-affirming care for ~1,000 inmates

The Supreme Court rejected a Trump administration emergency appeal Wednesday, leaving intact a lower court order that blocks enforcement of a February Bureau of Prisons policy ending hormone therapy,… pic.twitter.com/DTTCUNwBvf

— NewsTongue (@NewsTongueX) October 21, 2026

The administrative record describes a plan to align treatment with what the Bureau of Prisons views as the latest science, increase reliance on psychotherapy, and taper existing hormones under close medical oversight. The record also challenges standards tied to a leading professional group. These positions will be tested in court against evidence about patient outcomes, prior approvals by prison clinicians, and constitutional limits on withholding medically indicated care.

Why This Matters Beyond Today’s Ruling

This fight is part of a longer legal struggle over whether prisons may set blanket rules or must make individualized medical judgments for gender dysphoria. Federal appeals courts have split on which treatments are required in custody. Some have warned that denying doctor-recommended care for nonmedical reasons can violate the Constitution. Others have been more cautious, especially about surgery. The Supreme Court’s emergency denial keeps care flowing now but does not resolve those deeper disputes.

What To Watch Next

Watch for the appeals court schedule and any move to narrow or expand the injunction. Expect fresh data requests about how many inmates are affected, what treatments were stopped or tapered, and what safety issues the prisons document. The core test remains simple but tough: can the government override its own clinicians’ prior decisions with a broad policy, or must it justify changes one patient at a time with solid medical proof and workable security plans?